SPHK1 and multiple sclerosis: Importantly, a recent study has reported that upregulates the SphK1/S1P receptor signaling pathway may be a key factor of astrocytes mediated chronic inflammation in multiple sclerosis, and BBR ameliorated the severity of MS symptom in mouse model through inducing the increase in SphK1 and S1P.